Polar Capital Holdings PLC Igm Biosciences, Inc. Transaction History

Polar Capital Holdings PLC

  • $16.3 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$13.42 - $29.73 $1.43 Million - $3.16 Million
-106,436 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$27.59 - $66.39 $532,073 - $1.28 Million
19,285 Added 22.13%
106,436 $3.12 Million
Q3 2021

Nov 15, 2021
BUY
$65.76 - $90.65 $4.34 Million - $5.98 Million
66,007 Added 312.18%
87,151 $5.73 Million
Q2 2021

Aug 16, 2021
BUY
$57.98 - $96.6 $1.23 Million - $2.04 Million
21,144 New
21,144 $1.76 Million

Others Institutions Holding IGMS

# of Institutions
81
Shares Held
20.7M
Call Options Held
68K
Put Options Held
52.2K
View Full List

About IGM Biosciences, Inc.

IGMS Quotes by TradingView
  • Ticker IGMS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,969,000
  • Market Cap $189M
  • Description
  • IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...
More about IGMS
Track This Portfolio

Track Polar Capital Holdings PLC Portfolio

Follow Polar Capital Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Polar Capital Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Polar Capital Holdings PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email